Aurora Cannabis (NASDAQ:ACB - Get Free Report) is projected to announce its Q4 2025 earnings results before the market opens on Wednesday, June 18th. Analysts expect the company to announce earnings of $0.11 per share and revenue of $88.85 million for the quarter.
Aurora Cannabis Stock Performance
Aurora Cannabis stock traded down $0.24 during midday trading on Friday, hitting $5.85. 819,486 shares of the company were exchanged, compared to its average volume of 1,521,531. The firm has a market capitalization of $328.85 million, a PE ratio of 117.02 and a beta of 1.82. Aurora Cannabis has a fifty-two week low of $3.42 and a fifty-two week high of $7.20. The business has a fifty day simple moving average of $4.96 and a two-hundred day simple moving average of $4.72. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.60 and a current ratio of 3.30.
Institutional Trading of Aurora Cannabis
An institutional investor recently raised its position in Aurora Cannabis stock. Goldman Sachs Group Inc. raised its holdings in Aurora Cannabis Inc. (NASDAQ:ACB - Free Report) by 4.1% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 743,903 shares of the company's stock after purchasing an additional 29,099 shares during the period. Goldman Sachs Group Inc. owned about 1.32% of Aurora Cannabis worth $3,266,000 at the end of the most recent quarter. Institutional investors and hedge funds own 47.63% of the company's stock.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Read More
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
